Fig. 1 · Structure

Documents & Downloads

Sipuleucel-T

Cancer Vaccine

Sipuleucel-T is an immunotherapy targeting prostatic acid phosphatase (PAP), designed as a cancer vaccine for prostate cancer treatment. This therapy enhances the immune system's ability to recognize and attack prostate cancer cells by presenting PAP antigens. Sipuleucel-T is utilized in research applications focused on cancer immunology and therapeutic strategies aimed at enhancing anti-tumor immunity.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 917381-47-6
Applications Cancer Vaccine

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...